633 Time to deterioration of patient-reported outcomes in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Ingrid Boere,Bhavana Pothuri, Olena Sukhina, Tashanna Myers,Valentina Tuninetti,Angeles Alvarez Secord,Florian Heitz, Paul Nowicki,Annika Auranen,Nicole Nevadunsky,Lucy Gilbert, Michael J Callahan, Lyndsay Willmott,Michael A Gold,Matthew A Powell, Carolyn Mccourt, Veena Vincent, Veronika Simang,Mansoor Raza Mirza, Noelle Cloven

Oral Sessions(2024)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要